AbbVie reaffirms Q3 adjusted EPS guidance at $3.84-$3.88
AbbVie has affirmed its Q3 adjusted EPS guidance of $3.84-$3.88, unchanged from its prior range, versus a $3.84 analyst estimate.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AbbVie has affirmed its Q3 adjusted EPS guidance of $3.84-$3.88, unchanged from its prior range, versus a $3.84 analyst estimate.